Bristol-Myers Squibb Quarterly Income Statements Chart
Quarterly
|
Annual
Bristol-Myers Squibb Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net product sales | 11,909,000,000 | 10,886,000,000 | 11,811,000,000 | 11,483,000,000 | 11,925,000,000 | 11,559,000,000 | 11,168,000,000 | 10,645,000,000 | 10,917,000,000 | 11,048,000,000 | 11,065,000,000 | 10,813,000,000 | 11,485,000,000 | 11,308,000,000 | 11,609,000,000 | 11,243,000,000 | 11,405,000,000 | 10,798,000,000 | 10,766,000,000 | 10,197,000,000 | 9,817,000,000 | 10,541,000,000 | 7,662,000,000 | 5,768,000,000 | 6,031,000,000 | 5,713,000,000 | 5,715,000,000 | 5,433,000,000 | 5,461,000,000 | 4,972,000,000 | 5,046,000,000 | 4,862,000,000 | 4,770,000,000 | 4,580,000,000 | 4,814,000,000 | 4,492,000,000 | 4,432,000,000 | 3,964,000,000 | 3,862,000,000 | 3,552,000,000 | 3,572,000,000 | 3,059,000,000 | 3,240,000,000 | 2,843,000,000 | 2,770,000,000 | 2,807,000,000 | ||||||||||||||||
| alliance and other revenues | 360,000,000 | 315,000,000 | 531,000,000 | 409,000,000 | 276,000,000 | 306,000,000 | 309,000,000 | 321,000,000 | 309,000,000 | 289,000,000 | 341,000,000 | 405,000,000 | 402,000,000 | 340,000,000 | 376,000,000 | 381,000,000 | 298,000,000 | 275,000,000 | 302,000,000 | 343,000,000 | 312,000,000 | 240,000,000 | 283,000,000 | 239,000,000 | 242,000,000 | 207,000,000 | 258,000,000 | 258,000,000 | 243,000,000 | 221,000,000 | 403,000,000 | 392,000,000 | 374,000,000 | 349,000,000 | 429,000,000 | 430,000,000 | 439,000,000 | 427,000,000 | 425,000,000 | 517,000,000 | 591,000,000 | 982,000,000 | 1,018,000,000 | 1,078,000,000 | 1,119,000,000 | 1,004,000,000 | ||||||||||||||||
| total revenues | 12,269,000,000 | 11,201,000,000 | 12,342,000,000 | 11,892,000,000 | 12,201,000,000 | 11,865,000,000 | 11,477,000,000 | 10,966,000,000 | 11,226,000,000 | 11,337,000,000 | 11,406,000,000 | 11,218,000,000 | 11,887,000,000 | 11,648,000,000 | 11,985,000,000 | 11,624,000,000 | 11,703,000,000 | 11,073,000,000 | 11,068,000,000 | 10,540,000,000 | 10,129,000,000 | 10,781,000,000 | 7,945,000,000 | 6,007,000,000 | 6,273,000,000 | 5,920,000,000 | 5,973,000,000 | 5,691,000,000 | 5,704,000,000 | 5,193,000,000 | 5,449,000,000 | 5,254,000,000 | 5,144,000,000 | 4,929,000,000 | 5,243,000,000 | 4,922,000,000 | 4,871,000,000 | 4,391,000,000 | 4,287,000,000 | 4,069,000,000 | 4,163,000,000 | 4,041,000,000 | 4,258,000,000 | 3,921,000,000 | 3,889,000,000 | 3,811,000,000 | ||||||||||||||||
| yoy | 0.56% | -5.60% | 7.54% | 8.44% | 8.69% | 4.66% | 0.62% | -2.25% | -5.56% | -2.67% | -4.83% | -3.49% | 1.57% | 5.19% | 8.29% | 10.28% | 15.54% | 2.71% | 39.31% | 75.46% | 61.47% | 82.11% | 33.02% | 5.55% | 9.98% | 14.00% | 9.62% | 8.32% | 10.89% | 5.36% | 3.93% | 6.75% | 5.60% | 12.25% | 22.30% | 20.96% | 17.01% | 8.66% | 0.68% | 3.77% | 7.05% | 6.04% | ||||||||||||||||||||
| qoq | 9.53% | -9.24% | 3.78% | -2.53% | 2.83% | 3.38% | 4.66% | -2.32% | -0.98% | -0.60% | 1.68% | -5.63% | 2.05% | -2.81% | 3.11% | -0.68% | 5.69% | 0.05% | 5.01% | 4.06% | -6.05% | 35.70% | 32.26% | -4.24% | 5.96% | -0.89% | 4.96% | -0.23% | 9.84% | -4.70% | 3.71% | 2.14% | 4.36% | -5.99% | 6.52% | 1.05% | 10.93% | 2.43% | 5.36% | -2.26% | 3.02% | -5.10% | 8.59% | 0.82% | 2.05% | |||||||||||||||||
| cost of products sold | 3,372,000,000 | 3,033,000,000 | 4,812,000,000 | 2,957,000,000 | 3,267,000,000 | 2,932,000,000 | 2,745,000,000 | 2,506,000,000 | 2,876,000,000 | 2,566,000,000 | 2,593,000,000 | 2,353,000,000 | 2,720,000,000 | 2,471,000,000 | 2,356,000,000 | 2,291,000,000 | 2,452,000,000 | 2,841,000,000 | 2,910,000,000 | 2,502,000,000 | 2,699,000,000 | 3,662,000,000 | 2,432,000,000 | 1,810,000,000 | 1,992,000,000 | 1,844,000,000 | 1,690,000,000 | 1,648,000,000 | 1,625,000,000 | 1,584,000,000 | 1,673,000,000 | 1,572,000,000 | 1,562,000,000 | 1,259,000,000 | 1,383,000,000 | 1,305,000,000 | 1,206,000,000 | 1,052,000,000 | 952,000,000 | 1,097,000,000 | 1,013,000,000 | 847,000,000 | 966,000,000 | 1,007,000,000 | 991,000,000 | 968,000,000 | 1,273,000,000 | 1,175,000,000 | 1,108,000,000 | 1,063,000,000 | 1,075,000,000 | 987,000,000 | 1,245,000,000 | 1,303,000,000 | 1,367,000,000 | 1,407,000,000 | 1,481,000,000 | 1,343,000,000 | 1,414,000,000 | 1,280,000,000 | 1,277,000,000 | 1,306,000,000 |
| selling, general and administrative | 1,713,000,000 | 1,584,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| research and development | 2,580,000,000 | 2,257,000,000 | 3,191,000,000 | 2,374,000,000 | 2,899,000,000 | 2,695,000,000 | 2,478,000,000 | 2,242,000,000 | 2,258,000,000 | 2,321,000,000 | 2,510,000,000 | 2,418,000,000 | 2,321,000,000 | 2,260,000,000 | 2,607,000,000 | 3,251,000,000 | 3,271,000,000 | 2,225,000,000 | 3,750,000,000 | 2,499,000,000 | 2,522,000,000 | 2,372,000,000 | 2,087,000,000 | 1,382,000,000 | 1,328,000,000 | 1,351,000,000 | 1,380,000,000 | 1,280,000,000 | 2,435,000,000 | 1,250,000,000 | 1,921,000,000 | 1,543,000,000 | 1,659,000,000 | 1,288,000,000 | 1,400,000,000 | 1,138,000,000 | 1,266,000,000 | 1,136,000,000 | 1,916,000,000 | 1,132,000,000 | 1,856,000,000 | 1,016,000,000 | 1,189,000,000 | 983,000,000 | 1,416,000,000 | 946,000,000 | 957,000,000 | 893,000,000 | 951,000,000 | 930,000,000 | 1,082,000,000 | 951,000,000 | 962,000,000 | 909,000,000 | 1,008,000,000 | 973,000,000 | 923,000,000 | 935,000,000 | 1,010,000,000 | 824,000,000 | 822,000,000 | 910,000,000 |
| acquired iprd | 1,508,000,000 | 188,000,000 | 30,000,000 | 262,000,000 | 132,000,000 | 12,949,000,000 | 600,000,000 | 80,000,000 | 158,000,000 | 75,000,000 | 52,000,000 | 30,000,000 | 400,000,000 | 333,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| amortization of acquired intangible assets | 830,000,000 | 830,000,000 | 1,693,000,000 | 2,406,000,000 | 2,416,000,000 | 2,357,000,000 | 2,278,000,000 | 2,256,000,000 | 2,257,000,000 | 2,256,000,000 | 2,343,000,000 | 2,418,000,000 | 2,417,000,000 | 2,417,000,000 | 2,417,000,000 | 2,546,000,000 | 2,547,000,000 | 2,513,000,000 | 2,526,000,000 | 2,491,000,000 | 2,389,000,000 | 2,282,000,000 | ||||||||||||||||||||||||||||||||||||||||
| other (income)/expense | 494,000,000 | 339,000,000 | 305,000,000 | 234,000,000 | 273,000,000 | 81,000,000 | -371,000,000 | -258,000,000 | -116,000,000 | -413,000,000 | -217,000,000 | -140,000,000 | 284,000,000 | 649,000,000 | 393,000,000 | -409,000,000 | -2,000,000 | -702,000,000 | -1,826,000,000 | -915,000,000 | -736,000,000 | -344,250,000 | -191,000,000 | -539,000,000 | -647,000,000 | -87,000,000 | -224,000,000 | -454,000,000 | -520,000,000 | 328,000,000 | -323,000,000 | 107,000,000 | -299,000,000 | 799,000,000 | -277,000,000 | -104,000,000 | -208,000,000 | 20,000,000 | 5,000,000 | 199,000,000 | -19,000,000 | -35,000,000 | -50,000,000 | -18,000,000 | 23,000,000 | 26,000,000 | -26,000,000 | -31,000,000 | -138,000,000 | 42,000,000 | -10,000,000 | -19,000,000 | 113,000,000 | |||||||||
| total expenses | 10,496,000,000 | 8,230,000,000 | 12,167,000,000 | 10,216,000,000 | 10,915,000,000 | 23,381,000,000 | 9,803,000,000 | 8,829,000,000 | 9,367,000,000 | 8,567,000,000 | 9,547,000,000 | 9,009,000,000 | 9,929,000,000 | 9,961,000,000 | 10,127,000,000 | 9,467,000,000 | 10,150,000,000 | 8,543,000,000 | 21,519,000,000 | 8,283,000,000 | 8,502,000,000 | 11,085,000,000 | 8,074,000,000 | 4,658,000,000 | 4,497,000,000 | 3,941,000,000 | 4,468,000,000 | 3,524,000,000 | 5,187,000,000 | 3,414,000,000 | 4,751,000,000 | 4,071,000,000 | 3,849,000,000 | 2,974,000,000 | 4,157,000,000 | 3,363,000,000 | 3,256,000,000 | 2,736,000,000 | 4,697,000,000 | 3,082,000,000 | 4,111,000,000 | 2,593,000,000 | 4,318,000,000 | 2,913,000,000 | 3,441,000,000 | 2,826,000,000 | 3,572,000,000 | 3,247,000,000 | 3,518,000,000 | 3,157,000,000 | 3,678,000,000 | 4,995,000,000 | 3,384,000,000 | 3,224,000,000 | 3,860,000,000 | 3,515,000,000 | 3,644,000,000 | 3,244,000,000 | 3,698,000,000 | 3,184,000,000 | 3,176,000,000 | 3,355,000,000 |
| earnings before income taxes | 1,773,000,000 | 2,971,000,000 | 175,000,000 | 1,676,000,000 | 1,286,000,000 | -11,516,000,000 | 1,674,000,000 | 2,137,000,000 | 1,859,000,000 | 2,770,000,000 | 1,859,000,000 | 2,209,000,000 | 1,958,000,000 | 1,687,000,000 | 1,858,000,000 | 2,157,000,000 | 1,553,000,000 | 2,530,000,000 | -10,451,000,000 | 2,257,000,000 | 1,627,000,000 | -304,000,000 | -129,000,000 | 1,349,000,000 | 1,776,000,000 | 1,979,000,000 | 1,505,000,000 | 2,167,000,000 | 517,000,000 | 1,779,000,000 | 698,000,000 | 1,183,000,000 | 1,295,000,000 | 1,955,000,000 | 1,086,000,000 | 1,559,000,000 | 1,615,000,000 | 1,655,000,000 | -410,000,000 | 987,000,000 | 52,000,000 | 1,448,000,000 | -60,000,000 | 1,008,000,000 | 448,000,000 | 985,000,000 | 869,000,000 | 818,000,000 | 530,000,000 | 674,000,000 | 513,000,000 | -1,259,000,000 | 1,059,000,000 | 2,027,000,000 | 1,346,750,000 | 1,830,000,000 | 1,790,000,000 | 1,767,000,000 | ||||
| income tax provision/ | 460,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings | 1,313,000,000 | 2,462,000,000 | 76,000,000 | 1,215,000,000 | 1,684,000,000 | -11,908,000,000 | 1,762,000,000 | 1,934,000,000 | 2,077,000,000 | 2,267,000,000 | 2,025,000,000 | 1,608,000,000 | 1,429,000,000 | 1,283,000,000 | 2,372,000,000 | 1,552,000,000 | 1,061,000,000 | 2,029,000,000 | -10,027,000,000 | 1,878,000,000 | -80,000,000 | -766,000,000 | -1,060,000,000 | 1,366,000,000 | 1,439,000,000 | 1,715,000,000 | 1,158,000,000 | 1,912,000,000 | 382,000,000 | 1,495,000,000 | -2,329,000,000 | 856,000,000 | 922,000,000 | 1,526,000,000 | 898,000,000 | 1,215,000,000 | 1,188,000,000 | 1,206,000,000 | -188,000,000 | 730,000,000 | -110,000,000 | 1,199,000,000 | 27,000,000 | 732,000,000 | 334,000,000 | 936,000,000 | 735,000,000 | 692,000,000 | 530,000,000 | 623,000,000 | 924,000,000 | -713,000,000 | 808,000,000 | 1,482,000,000 | 1,231,000,000 | 1,355,000,000 | 1,307,000,000 | 1,367,000,000 | 842,000,000 | 1,302,000,000 | 1,268,000,000 | 1,101,000,000 |
| yoy | -22.03% | -120.68% | -95.69% | -37.18% | -18.92% | -625.28% | -12.99% | 20.27% | 45.35% | 76.70% | -14.63% | 3.61% | 34.68% | -36.77% | -123.66% | -17.36% | -1426.25% | -364.88% | 845.94% | 37.48% | -105.56% | -144.66% | -191.54% | -28.56% | 276.70% | 14.72% | -149.72% | 123.36% | -58.57% | -2.03% | -359.35% | -29.55% | -22.39% | 26.53% | -577.66% | 66.44% | -1180.00% | 0.58% | -796.30% | -0.27% | -132.93% | 28.10% | -96.33% | 5.78% | -36.98% | 50.24% | -20.45% | -197.05% | -34.41% | -57.96% | -24.94% | -152.62% | -38.18% | 8.41% | 46.20% | 4.07% | 3.08% | 24.16% | ||||
| qoq | -46.67% | 3139.47% | -93.74% | -27.85% | -114.14% | -775.82% | -8.89% | -6.88% | -8.38% | 11.95% | 25.93% | 12.53% | 11.38% | -45.91% | 52.84% | 46.28% | -47.71% | -120.24% | -633.92% | -2447.50% | -89.56% | -27.74% | -177.60% | -5.07% | -16.09% | 48.10% | -39.44% | 400.52% | -74.45% | -164.19% | -372.08% | -7.16% | -39.58% | 69.93% | -26.09% | 2.27% | -1.49% | -741.49% | -125.75% | -763.64% | -109.17% | 4340.74% | -96.31% | 119.16% | -64.32% | 27.35% | 6.21% | 30.57% | -14.93% | -32.58% | -229.59% | -188.24% | -45.48% | 20.39% | -9.15% | 3.67% | -4.39% | 62.35% | -35.33% | 2.68% | 15.17% | |
| net income margin % | 10.70% | 21.98% | 0.62% | 10.22% | 13.80% | -100.36% | 15.35% | 17.64% | 18.50% | 20.00% | 17.75% | 14.33% | 12.02% | 11.01% | 19.79% | 13.35% | 9.07% | 18.32% | -90.59% | 17.82% | -0.79% | -7.11% | -13.34% | 22.74% | 22.94% | 28.97% | 19.39% | 33.60% | 6.70% | 28.79% | -42.74% | 16.29% | 17.92% | 30.96% | 17.13% | 24.69% | 24.39% | 27.47% | -4.39% | 17.94% | -2.64% | 29.67% | 0.63% | 18.67% | 8.59% | 24.56% | ||||||||||||||||
| noncontrolling interest | 2,000,000 | 6,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 3,000,000 | 6,000,000 | 4,000,000 | 5,000,000 | 3,000,000 | 2,000,000 | 8,000,000 | 5,000,000 | 6,000,000 | 6,000,000 | 8,000,000 | 6,000,000 | 5,000,000 | 9,000,000 | -4,000,000 | 13,000,000 | 7,000,000 | 5,000,000 | -2,000,000 | 11,000,000 | 9,000,000 | 9,000,000 | |||||||||||||||||||||||||||||||||||
| net earnings attributable to bms | 1,310,000,000 | 2,456,000,000 | 72,000,000 | 1,211,000,000 | 1,680,000,000 | -11,911,000,000 | 1,762,000,000 | 1,928,000,000 | 2,073,000,000 | 2,262,000,000 | 2,022,000,000 | 1,606,000,000 | 1,421,000,000 | 1,278,000,000 | 2,372,000,000 | 1,546,000,000 | 1,055,000,000 | 2,021,000,000 | -10,027,000,000 | 1,872,000,000 | -85,000,000 | -775,000,000 | -1,056,000,000 | 1,353,000,000 | 1,432,000,000 | 1,710,000,000 | 1,160,000,000 | 1,901,000,000 | 373,000,000 | 1,486,000,000 | -2,328,000,000 | 845,000,000 | 916,000,000 | 1,574,000,000 | 894,000,000 | 1,202,000,000 | 1,166,000,000 | 1,195,000,000 | -197,000,000 | 706,000,000 | -130,000,000 | 1,186,000,000 | 13,000,000 | 721,000,000 | 333,000,000 | 937,000,000 | 726,000,000 | 692,000,000 | 536,000,000 | 609,000,000 | 925,000,000 | -711,000,000 | ||||||||||
| earnings/(loss) per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 640,000 | 1,210,000 | -1,112,500 | 600,000 | 830,000 | 155,000 | -430,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 640,000 | 1,200,000 | -1,112,500 | 600,000 | 830,000 | 152,500 | -430,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax provision | 509,000,000 | 99,000,000 | 461,000,000 | -398,000,000 | 392,000,000 | -88,000,000 | 203,000,000 | -218,000,000 | 503,000,000 | -166,000,000 | 601,000,000 | 529,000,000 | 404,000,000 | -514,000,000 | 605,000,000 | 492,000,000 | 501,000,000 | 1,707,000,000 | 462,000,000 | 931,000,000 | -17,000,000 | 337,000,000 | 264,000,000 | 347,000,000 | 255,000,000 | 135,000,000 | 284,000,000 | 3,027,000,000 | 327,000,000 | 373,000,000 | 429,000,000 | 188,000,000 | 344,000,000 | 427,000,000 | 449,000,000 | -222,000,000 | 257,000,000 | 162,000,000 | 249,000,000 | 109,750,000 | 276,000,000 | 114,000,000 | 49,000,000 | 51,000,000 | 251,000,000 | 545,000,000 | 363,000,000 | 475,000,000 | 483,000,000 | 400,000,000 | 571,000,000 | 312,000,000 | 324,000,000 | 351,000,000 | ||||||||
| marketing, selling and administrative | 2,136,000,000 | 1,983,000,000 | 1,928,000,000 | 2,367,000,000 | 2,073,000,000 | 2,003,000,000 | 1,934,000,000 | 1,762,000,000 | 2,266,000,000 | 1,930,000,000 | 1,787,000,000 | 1,831,000,000 | 2,354,000,000 | 1,788,000,000 | 1,882,000,000 | 1,666,000,000 | 2,721,000,000 | 1,706,000,000 | 1,628,000,000 | 1,606,000,000 | 1,734,000,000 | 1,055,000,000 | 1,076,000,000 | 1,006,000,000 | 1,336,000,000 | 1,104,000,000 | 1,131,000,000 | 980,000,000 | 1,299,000,000 | 1,147,000,000 | 1,167,000,000 | 1,074,000,000 | 1,461,000,000 | 1,144,000,000 | 1,238,000,000 | 1,068,000,000 | 1,996,000,000 | 983,000,000 | 968,000,000 | 894,000,000 | 1,151,000,000 | 1,029,000,000 | 951,000,000 | 957,000,000 | 1,068,000,000 | 980,000,000 | 1,042,000,000 | 994,000,000 | 1,143,000,000 | 1,071,000,000 | 1,004,000,000 | 1,002,000,000 | 1,216,000,000 | 1,019,000,000 | 1,040,000,000 | 928,000,000 | 1,000,000,000 | 892,000,000 | 894,000,000 | 900,000,000 | ||
| earnings per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | -5,890,000 | 870,000 | 940,000 | 990,000 | 1,080,000 | 960,000 | 750,000 | 670,000 | 600,000 | 1,070,000 | 700,000 | 470,000 | 900,000 | -4,440,000 | 830,000 | -40,000 | -340,000 | -730,000 | 830,000 | 880,000 | 1,050,000 | 710,000 | 1,160,000 | 230,000 | 910,000 | -1,410,000 | 520,000 | 560,000 | 950,000 | 540,000 | 720,000 | 700,000 | 720,000 | -120,000 | 420,000 | -80,000 | 710,000 | 10,000 | 430,000 | 200,000 | 570,000 | 440,000 | 420,000 | 330,000 | 370,000 | 380,000 | 650,000 | 510,000 | 570,000 | 530,000 | 580,000 | 280,000 | 550,000 | 540,000 | 430,000 | |||||||
| diluted | -5,890,000 | 870,000 | 930,000 | 990,000 | 1,070,000 | 950,000 | 750,000 | 660,000 | 590,000 | 1,070,000 | 690,000 | 470,000 | 890,000 | -4,430,000 | 820,000 | -40,000 | -340,000 | -740,000 | 830,000 | 870,000 | 1,040,000 | 710,000 | 1,160,000 | 230,000 | 910,000 | -1,410,000 | 510,000 | 560,000 | 940,000 | 530,000 | 720,000 | 690,000 | 710,000 | -120,000 | 420,000 | -80,000 | 710,000 | 10,000 | 430,000 | 200,000 | 560,000 | 430,000 | 420,000 | 320,000 | 370,000 | 380,000 | 640,000 | 500,000 | 560,000 | 520,000 | 570,000 | 280,000 | 550,000 | 530,000 | 430,000 | |||||||
| provision/(benefit) for income taxes | 637,000,000 | 379,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income/(income) | 1,163,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | 63,000,000 | 411,000,000 | 101,000,000 | -260,000,000 | 62,000,000 | -508,000,000 | -4,000,000 | -400,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash dividends declared per common share | 300,000 | 400,000 | 400,000 | 400,000 | 400,000 | 390,000 | 390,000 | 390,000 | 390,000 | 380,000 | 380,000 | 380,000 | 380,000 | 370,000 | 370,000 | 370,000 | 370,000 | 360,000 | 360,000 | 360,000 | 360,000 | 350,000 | 350,000 | 350,000 | ||||||||||||||||||||||||||||||||||||||
| net earnings/(loss) attributable to noncontrolling interest | -7,750,000 | 11,000,000 | 6,000,000 | -48,000,000 | 13,000,000 | 1,000,000 | -1,000,000 | 2,000,000 | -6,000,000 | 135,500,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings attributable to noncontrolling interest | 4,000,000 | 13,000,000 | 22,000,000 | 11,000,000 | 9,000,000 | 24,000,000 | 20,000,000 | 14,000,000 | 11,000,000 | 14,000,000 | 163,000,000 | 381,000,000 | 379,000,000 | 386,000,000 | 405,000,000 | 381,000,000 | 359,000,000 | 353,000,000 | 341,000,000 | 358,000,000 | ||||||||||||||||||||||||||||||||||||||||||
| advertising and product promotion | 123,750,000 | 193,000,000 | 167,000,000 | 135,000,000 | 213,000,000 | 171,000,000 | 187,000,000 | 163,000,000 | 254,000,000 | 194,000,000 | 218,000,000 | 189,000,000 | 212,000,000 | 167,000,000 | 224,000,000 | 194,000,000 | 285,000,000 | 205,000,000 | 253,000,000 | 214,000,000 | 271,000,000 | 231,000,000 | 263,000,000 | 212,000,000 | ||||||||||||||||||||||||||||||||||||||
| net sales | 2,986,000,000 | 4,065,000,000 | 4,048,000,000 | 3,831,000,000 | 4,191,000,000 | 3,736,000,000 | 4,443,000,000 | 5,251,000,000 | 5,454,000,000 | 5,345,000,000 | 5,434,000,000 | 5,011,000,000 | 5,111,000,000 | 4,798,000,000 | 4,768,000,000 | 4,807,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| impairment charge for bms-986094 intangible asset | 1,830,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit from/(benefit from) income taxes | 134,000,000 | 126,000,000 | -411,000,000 | -546,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit from restructuring | 17,750,000 | 29,000,000 | 20,000,000 | 22,000,000 | 24,000,000 | 8,000,000 | 40,000,000 | 44,000,000 | 63,000,000 | 15,000,000 | 24,000,000 | 11,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| litigation expense/ | -30,500,000 | 50,000,000 | -172,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| equity in net income of affiliates | -37,500,000 | -40,000,000 | -53,000,000 | -57,000,000 | -66,000,000 | -71,000,000 | -62,000,000 | -82,000,000 | -61,000,000 | -70,000,000 | -85,000,000 | -97,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings/(loss) per common share attributable to bms | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 640,000 | 1,210,000 | -1,112,500 | 600,000 | 830,000 | 155,000 | -430,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 640,000 | 1,200,000 | -1,112,500 | 600,000 | 830,000 | 152,500 | -430,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| dividends declared per common share | 255,000 | 340,000 | 340,000 | 340,000 | 340,000 | 330,000 | 330,000 | 330,000 | 330,000 | 320,000 | 320,000 | 320,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings attributable to bristol-myers squibb company | 645,000,000 | 1,101,000,000 | 852,000,000 | 969,000,000 | 902,000,000 | 986,000,000 | 483,000,000 | 949,000,000 | 927,000,000 | 743,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| litigation expense | -41,000,000 | 22,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings from continuing operations before income taxes | 1,413,000,000 | 1,614,000,000 | 1,592,000,000 | 1,452,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings from continuing operations | 842,000,000 | 1,302,000,000 | 1,268,000,000 | 1,101,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings, net of taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gain on disposal, net of taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net earnings from discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| amounts attributable to bristol-myers squibb company: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings per common share attributable to bristol-myers squibb company: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income from discontinued operations |
We provide you with 20 years income statements for Bristol-Myers Squibb stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bristol-Myers Squibb stock. Explore the full financial landscape of Bristol-Myers Squibb stock with our expertly curated income statements.
The information provided in this report about Bristol-Myers Squibb stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.